top of page

Transforming
UTERINE HEALTH

through intrauterine treatments

Screenshot 2025-06-12 13.19.40-Photoroom.png
Screenshot 2025-06-12 13.16.37-Photoroom.png

Our treatments

Screenshot 2025-06-12 14.40.55.png

Womed has developed Womed Leaf®, a treatment for women whose uterus is scarred and subject to repeated miscarriages.

Screenshot 2025-06-12 14.51.34.png

Womed is developing a low dose, targeted, intrauterine effective treatment to reduce abnormal bleeding associated with fibroids.

Screenshot 2025-06-12 14.56.24.png

Womed is developing a new intrauterine drug delivery system to alleviate the tremendous suffering of women with endometriosis and help them lead a normal life.

Screenshot 2025-06-12 14.42.42.png

Womed is developing a rapid and effective treatment for women presenting to the emergency suite with acute uterine bleeding.

Latest news

Womed Leaf Now Available in the U.S. to Protect and Restore Uterine Health

Womed Leaf, the first FDA-approved resorbable adhesion barrier for Asherman syndrome, will be distributed in the United States by global endoscopic technology leader KARL STORZ.

This collaboration provides U.S. gynecologists with a clinically validated solution to reduce the severity of intrauterine adhesions after hysteroscopic adhesiolysis.

bottom of page